MANCHESTER, United Kingdom and HYDERABAD, India, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), Agility Life ...
Pharmaceutical Technology on MSN
Biogen’s high-dose Spinraza turned down by FDA due to CMC troubles
The US Food and Drug Administration (FDA) has rejected Biogen’s high-dose Spinraza (nusinersen) for the treatment of spinal muscular atrophy (SMA). The agency chose to decline the antisense ...
In partnership with Agility Life Sciences and Centrix Pharma Solutions Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions today announced the launch of an Integrated CMC ...
The complex regulatory landscape for biological drug products presents opportunities in mastering Chemistry, Manufacturing, and Controls (CMC) requirements, especially for varying molecule types. This ...
Stay informed on key pharmaceutical news, including tariff updates, FDA shutdown risks, and insights from recent cell and ...
Stay informed on key pharmaceutical news, including FDA insights, Takeda's strategic shifts, and updated CDC COVID-19 ...
How cell and gene therapy developers can lessen the chances of receiving FDA complete response letters through the use of ...
Milestone Pharmaceuticals Inc. is advancing CARDAMYST, a self-administered nasal spray for PSVT. Click here to read why MIST ...
Mycenax Biotech Inc. (TWO:4726), a leading biologics CDMO based in Taiwan, today announced strategic alliance with SPERA PHARMA Inc., a Japan-based expert in pharmaceutical Chemistry, Manufacturing, ...
Dr. Singh underscored India’s remarkable progress in the biotechnology and pharmaceutical sectors, calling it a key driver of ...
The Ritedose Corporation announced a $17M investment to expand its in-house cGMP laboratory facilities, enhancing its analytical chemistry and microbiology capabilities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback